SOURCE:
IO News Wire
2008-08-21 13:58:00
(OVIT.OB) OncoVista Issued $16 Price Target From Status Equity Research
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO News Wire
NEW YORK, NY–(EMWNews – August 21, 2008) – OncoVista Innovative Therapies, Inc. (
commercialization of targeted cancer therapies and diagnostics.
According to the Status Equity Research report published August 12, 2008,
the world market for in vitro diagnostic (IVD) tests for cancer is growing
at 11% annually and could reach $8 billion by the end of 2012.
Status concludes that a successful market launch and penetration of OVIT’s
AdnaTest, can yield $80 million in first year, post launch sales in the
U.S. in 2010.
The research report can be accessed at STATUS EQUITY RESEARCH REPORT — OVIT
Other active stocks are Johnson & Johnson (
For More Information on OncoVista Innovative Therapies, Inc. please visit:
For More Information on Status Equity Research please visit:
About Status Equity Research
Status Equity Research is a monthly publication committed to providing
coverage on unique emerging growth companies that can become sector leaders
in the U.S. equity markets.
About OncoVista, Inc.
OncoVista is a biopharmaceutical company engaged in the development and
commercialization of targeted cancer therapies both through the acquisition
of rights to technologies and drugs from others and through the development
of proprietary products. OncoVista focuses on candidates that have been
previously tested in human clinical trials or animal models, as well as
technologies that may improve the delivery or targeting of previously
tested, and in some cases marketed, anticancer agents.
Information, opinions and analysis contained herein are based on sources
believed to be reliable, but no representation, expressed or implied, is
made as to its accuracy, completeness or correctness. The opinions
contained herein reflect our current judgment and are subject to change
without notice. We accept no liability for any losses arising from an
investor’s reliance on or use of this report. This report is for
information purposes only, and is neither a solicitation to buy nor an
offer to sell securities. A third party has hired and paid IO News Wire
$2,495.00 for the publication and circulation of this news release. Certain
information included herein is forward-looking within the meaning of the
Private Securities Litigation Reform Act of 1995, including, but not
limited to, statements concerning manufacturing, marketing, growth, and
expansion. Such forward-looking information involves important risks and
uncertainties that could affect actual results and cause them to differ
materially from expectations expressed herein. We have no ownership of
equity, no representation do no trading of any kind and send No Faxes or
emails.
Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89
Get Unlimited Organic Website Traffic to your Website
TheNFG.com now offers Organic Lead Generation & Traffic Solutions